Lecture Notes: Healthy Skepticism, DSM Evolution, Rosenhan Study, and Experimental Design in Abnormal Psychology

Healthy Skepticism and Methodologies in Abnormal Psychology

  • Context of today’s class discussion

    • Revisit definition of mental disorders and clinical components for building a clinical picture.
    • Begin with a healthy skeptic’s perspective on mental illness, then move to research methodologies and assessment techniques (surveys, neuroimaging, interviews).
    • Expect this topic to spill over into next week.

  • Class logistics and reminders (announcements replicated from transcript)

    • No class on Monday due to the instructor attending grandmother’s 100th birthday party in Iowa; class canceled and will resume Wednesday.
    • Assignment 1 will be given on Wednesday with directions; due the following Friday (roughly a two-day turnaround will be provided, deemed reasonable).
    • Expect two three-day weekends, with normal schedule otherwise, leading into fall break.
    • If you have questions, bring them to class before starting the lecture.

  • Big picture: mental illness, DSM, and the balancing act between art and science

    • DSM = Diagnostic and Statistical Manual of Mental Disorders; it currently catalogs well over 300 disorders with diagnostic criteria.
    • Societal belief generally accepts that mental illness is real, but there are skeptical viewpoints that deserve respectful consideration.
    • Diagnosis is described as part art and part science; requires skilled, experienced clinicians to determine when a diagnosis is warranted.
    • The DSM evolves over time as physiology, biochemistry, neurology, and sociocultural understanding change.

  • Two notable skeptical perspectives introduced

    • Thomas Szasz (often cited as criticizing psychiatry): argues that
    • Mental illness is a myth; illness should be defined by a demonstrable biological pathological process.
    • Observing incomprehensible speech in schizophrenia, for example, does not necessarily reveal a biological brain pathology.
    • Diagnosing mental illness can stigmatize individuals and turn labels into self-fulfilling roles (social construct argument).
    • Szasz’s stance is controversial; he was a psychiatrist himself, which the lecturer uses to show diversity of perspective within the field.
    • The instructor’s interpretation: having diverse viewpoints helps keep the field honest and prevents blind spots; critical thinking and evidence-based argumentation are essential rather than reflexive agreement with one camp.
    • Practical note on labeling:
    • A label can influence how others perceive and interact with a person (the “humanity/dignity” impact).
    • Clinicians must balance not missing important symptoms with avoiding unnecessary stigmatization.

  • The Rosenhan study as a pivotal critique of labeling and diagnosis

    • Study: Rosenhan and seven colleagues (eight pseudopatients total) pretended to hear voices and presented themselves to various inpatient psychiatric facilities.
    • Procedure details:
    • Each pseudopatient reported hearing a voice saying a single syllable (“thud, empty, and hollow”) and sought admission.
    • Once admitted, they acted normally and did not claim ongoing symptoms.
    • If admitted, they stayed long enough to be discharged, ultimately with a diagnosis of schizophrenia in remission.
    • Key quantitative findings:
    • Average length of stay across facilities: extaveragestay=19extdaysext{average stay} = 19 ext{ days}
    • Range of stays: extrange=[7,52]extdaysext{range} = [7, 52] ext{ days}
    • Outcome and implications:
    • None of the pseudopatients were reliably detected as impostors; all received schizophrenia diagnoses upon discharge.
    • This study highlighted the power of labeling and the susceptibility of staff to interpret behavior through the lens of a diagnostic category (the “schizophrenia filter”).
    • The title of the paper: “Being Sane in Insane Places.”
    • Context about ethics and methodology:
    • Rosenhan alerted hospital administrators beforehand but did not reveal the study to staff; the deception raises ethical questions about research practices.
    • The study prompted ongoing discussion about observer bias, diagnostic stigma, and the limits of clinical assessment in real-world settings.
    • Takeaway for clinical practice and research ethics:
    • Labels can shape perception and behavior, potentially leading to overpathologizing or misinterpretation of normal variation.
    • The need for humility and ongoing evaluation of diagnostic practices, along with consideration of alternative perspectives.
    • Confidentiality and minimizing harm in research design, including obfuscation of identifying information in reporting results; caution about naming institutions or individuals in public reports.
    • Related reflections from the lecturer:
    • It’s important to consider the broader implications for patients and clinicians when labels are used, and to avoid public shaming of facilities.
    • Even in normal, non-deceptive research, confidentiality and protecting participants from harm are standard professional practices.

  • DSM evolution and the interplay of science and culture

    • The DSM has evolved since the 1950s; it reflects both advances in neuroscience and shifts in social norms.
    • Timeline highlights:
    • PTSD added as a diagnosable disorder in 1980 (DSM-III) — PTSD is widely discussed today due to wars and widespread trauma; skeptics might question why it took until 1980 to include it, given historical traumatic experiences.
    • Homosexuality was removed as a diagnosable mental disorder in 1980 — reflecting changing cultural and scientific understanding.
    • Ongoing debates, especially around personality disorders:
    • The DSM-IV to DSM-5 transition included extensive discussion about personality disorders but ultimately did not change their classification in DSM-5.
    • This illustrates the “art and science” balance: clinicians and researchers recognize problems but may not reach a mutually agreed update immediately.
    • Practical implications of DSM changes:
    • Clinicians must stay informed about updates and understand that diagnostic criteria are not fixed forever; they can reflect new evidence and sociocultural context.
    • Public discourse often oversimplifies diagnoses (e.g., labeling someone as “the schizophrenic”) without recognizing the complexities and uncertainties involved in diagnosis.
    • Educational takeaway:
    • Expect changes over time; be prepared to justify diagnostic decisions with evidence and to acknowledge limitations of current criteria.

  • Scientifically studying abnormality: common methodologies

    • Core idea: the methods discussed are general scientific methods applicable beyond psychology; the focus is how they apply to abnormal psychology.
    • Experimental design: a canonical approach to testing causal hypotheses.
    • Key components of an experimental design (as presented):
    • Hypothesis statement: a testable claim about differences between groups.
    • Population of interest: the broader group you want to understand (e.g., people with depression).
    • Sample: a smaller subset drawn from the population of interest (e.g., 100 people with depression).
    • Recruitment and sampling:
      • Ideally random sampling from the population, but in practice participants are often self-selected via advertisements and referrals.
      • Sampling method acknowledged as a limitation when it is not truly random (self-selection bias).
    • Random assignment: participants are randomly assigned to different groups or conditions to control for pre-existing differences.
    • Independent variable (IV): the factor that the researcher manipulates (e.g., exercise behavior).
    • Dependent variable (DV): the outcome measured to assess the effect of the IV (e.g., depression levels).
    • Two-group design example (illustrative):
      • Experimental group: receives the treatment/level of the IV (e.g., regular exercise).
      • Control group: does not receive the treatment (e.g., no exercise).
    • Levels/conditions: the distinct states of the IV (e.g., Exercise vs. No Exercise) — sometimes described as levels or conditions.
    • Note on terminology:
      • PS = participants; random assignment is a core methodological safeguard to ensure equivalent groups and reduce bias.
    • Worked example from the lecture:
    • Hypothesis example: I hypothesize that people who do regular exercise programs will have significantly less depression compared to people who don’t.
    • Formalized hypotheses (one-tailed):
      • H<em>0:μ</em>extexercisegeμextnoexerciseH<em>0: \mu</em>{ ext{exercise}} \\ge \mu_{ ext{no exercise}}
      • H1: \mu{ ext{exercise}} < \mu_{ ext{no exercise}}
    • IV and DV in this example:
      • Independent variable: \text{exercise behavior} \
      • Dependent variable: \text{depression}
    • Population of interest: \text{people with depression}
    • Sample size: \text{n} = 100
    • Recruitment methods (illustrative): flyers in mental health offices, hospitals, word-of-mouth, etc.; participants may self-select
    • Random assignment to groups is emphasized as critical to balance out individual differences
    • Conceptual recap: key vocabulary
    • Independent variable (IV): what the researcher manipulates
    • Dependent variable (DV): what is measured
    • Population of interest: the broader group under study
    • Sample: the subset actually studied
    • Random sampling vs self-selection: ideal vs practical realities
    • Random assignment: ensures comparability of groups at baseline
    • Additional example to illustrate variable roles
    • A classroom-style example: manipulation of lighting as an IV (lights on vs lights off) and the DV as note-taking performance under those conditions; demonstrates the idea that researchers choose what to manipulate and what to measure

  • Key takeaways and ethical considerations in research on abnormality

    • The importance of skepticism balanced with empirical evidence; multiple viewpoints can help avoid bias and improve understanding
    • The role of neuroimaging and modern techniques in demonstrating brain differences associated with psychiatric conditions, contrasted with Szasz’s cautions about labeling
    • Ethical issues raised by Rosenhan’s study and the broader issue of protecting participants and facilities from harm, stigma, or undue exposure
    • The need for confidentiality and responsible reporting to protect participants and minimize harm; obfuscation of identifiable details is standard practice
    • The reality that diagnosis is not infallible; clinicians should be mindful of biases and remain open to re-evaluation as new data emerge

  • Connections to broader themes

    • Real-world relevance: how diagnostic categories influence treatment, stigma, access to care, and patient identities
    • Foundational principles: science is iterative; our understanding of mental disorders evolves with advances in biology, technology, and social context
    • Ethical implications: balancing patient welfare, scientific inquiry, and societal impact of labeling mindset and diagnoses

  • Summary of essential terms and figures to remember

    • DSM: Diagnostic and Statistical Manual of Mental Disorders, with >300300 disorders and diagnostic criteria
    • PTSD: added to DSM in 19801980 (as part of DSM-III)
    • Homosexuality: listed as a diagnosable condition prior to 19801980, removed in 19801980
    • Szasz (Thomas Szasz): argues mental illness is a myth; illness requires demonstrable biological pathology; labeling can stigmatize and act as a social construct
    • Rosenhan (Being Sane in Insane Places): pseudo-patients admitted with schizophrenia diagnosis despite normal behavior; high average length of stay; illustrates labeling effects and the need for critical assessment of diagnostic practices
    • PS: abbreviation for participants
    • IV vs DV: key variables in experimental design; IV manipulated by the researcher; DV measured to assess effect
    • Hypotheses: formal statements guiding experimental tests; often include null and alternative forms

  • Final reflection for exam preparation

    • Be able to articulate why DSM changes occur and how social and scientific developments influence diagnostic criteria
    • Understand why skepticism toward psychiatric labels is both valuable and potentially dangerous if not grounded in evidence
    • Be comfortable with the basic structure of experimental design, including how to specify IVs, DVs, population, sampling, and random assignment
    • Know the Rosenhan study’s design, outcomes, and implications for clinical practice and research ethics